Skip to content

Drug interactions

Everolimus + Influenza virus vaccine trivalent recombinant

Severity: Moderate

Everolimus and Influenza virus vaccine trivalent recombinant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Everolimus is an immunosuppressant and can blunt the antibody response to vaccination. The recombinant vaccine is non-live and safe to give, but protection may be less than in immunocompetent patients.

What this interaction means in plain words

Everolimus and Influenza virus vaccine trivalent recombinant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

mTOR inhibition suppresses lymphocyte proliferation and reduces the vaccine immune response.

What to do

Vaccinate as recommended, ideally before starting everolimus when feasible, and do not withhold the non-live vaccine. Remain alert for influenza despite vaccination and consider other preventive measures.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Everolimus and Influenza virus vaccine trivalent recombinant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Everolimus with Influenza virus vaccine trivalent recombinant?

MediHelp rates the interaction as moderate. Everolimus and Influenza virus vaccine trivalent recombinant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Everolimus is an immunosuppressant and can blunt the antibody response to vaccination. The recombinant vaccine is non-live and safe to give, but protection may be less than in immunocompetent patients.

How serious is the interaction between Everolimus and Influenza virus vaccine trivalent recombinant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate as recommended, ideally before starting everolimus when feasible, and do not withhold the non-live vaccine. Remain alert for influenza despite vaccination and consider other preventive measures.

What other medicines interact with Everolimus?

MediHelp also lists interactions of Everolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Levoketoconazole. The full list is on the Everolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in